Management articulated a comprehensive new strategy in Feb14 aimed at transforming growth, lifting margins and boosting earnings quality. Alongside an exciting & innovative pipeline of new products hitting the market over the next few weeks, FY15 results confirm the plan is bearing fruit. Whilst it’s taken slightly longer than hoped, this marks an important inflection point in the company’s history and the 3-year EPS CAGR to Jun’18 could top 50% and propel EPS to 22p (vs Jun’15 6.5p). A re-ratin ....
